Results 121 to 130 of about 157,671 (305)

Analisis Framing Pemberitaan Vaksin Covid-19 Oxford-Astrazeneca di Indonesia

, 2022
There are several online news sites in Indonesia, such as Kompas.com and Tempo.com. In reporting on COVID-19, especially information on vaccine developments, both media such as Kompas.com and Tempo.com each frame the information obtained and then publish
Waluyo, Lukman Saleh, Subakti, Dian Rahmawati   +1 more
core  

Distinct molecular pathways supporting Sjögren's Disease clusters and disease progression.

Arthritis &Rheumatology, Accepted Article.
Objective Sjögren's disease (SjD) is a heterogeneous autoimmune disease. We aimed to investigate blood transcriptomic signatures and disease progression among three recently defined SjD patient clusters: (1) B‐cell active with low symptoms (BALS), (2) high systemic activity (HSA), and (3) low systemic activity with high symptoms (LSAHS).
Sacha E Silva‐Saffar, Yann Nguyen, Raphaèle Seror, Jacques‐Eric Gottenberg, Anna Niarakis, Xavier Mariette, Gaetane Nocturne   +6 more
wiley   +1 more source

Preparation and ring-opening reactions of N-diphenylphosphinyl vinyl aziridines

, 2013
Predominantly (E)-N-diphenylphosphinyl vinyl aziridines are prepared by a reaction of N-diphenylphosphinyl imines with α-bromoallyllithium in the presence of freshly fused ZnCl2. These aziridines undergo a ring-opening reaction with a variety of carbon
McClaren, Andrew B., Osborn, Helen M. I., Joseph Sweeney, McLaren, Andrew B., Jarvis, Ashley N., Sweeney, Joseph B., Helen M. I. Osborn, Ashley N. Jarvis, Sweeney, Joseph, Andrew B. McLaren   +9 more
core   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

npj Breast Cancer, 2023
Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, Susana Ros, Cath Eberlein, Jennifer I. Moss, Jelena Urosevic, Larissa S. Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J. A. Goodwin, Brandon S. Willis, Claire Rooney, Elza DeBruin, Simon T. Barry   +20 more
doaj   +2 more sources

Equity valuation: AstraZeneca, PLC

This dissertation aims to present the estimation of the fair value of AstraZeneca,Plc (AZN) at the end of December 31, 2022. After a review of the company and its sector, three approached will be presented to value the company.
Santos, Rafaela Alexandra Mendes dos
core  

AstraZeneca - mycket väsen för ingenting?

, 2011
Genom den principiellt viktiga domen i AstraZeneca-målet har två nya missbrukstyper fastslagits, som utvidgar tillämpningsområdet för artikel 102 FEUF, dvs. förbudet mot missbruk av en dominerande ställning.
Bastidas Venegas, Vladimir,
core  

Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements

British Journal of Clinical Pharmacology, EarlyView.
Within the ConcePTION project we set out to design two mother–infant pair studies collecting breast milk and plasma from the mother and plasma from the infant (for metformin and prednisolone) in order to demonstrate the premises and conditions for investigating potential drug transfer in association with breastfeeding.
Mats Hansson, Ida Björkgren, Jenny Svedenkrans, Helena Backman, Jarl Hellman, Linda Englund‐Ögge, Mikaela Magnusson, Inger Lindström, Andrea Wutte, Erica Sundell, Pawel Baranczewski, Laura Shaughnessy   +11 more
wiley   +1 more source

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Risankizumab is a high‐cost biologic treatment for chronic plaque psoriasis, an immune‐mediated inflammatory disease presenting with painful red scaly skin lesions. Inter‐individual heterogeneity in treatment response may be better addressed with personalised rather than fixed dosing. We sought to develop a pharmacokinetic/pharmacodynamic (
Charlotte M. Thomas, Jessica Ruoheng Wei, David Baudry, Zehra Arkir, Bola Coker, Tejus Dasandi, Kingsley Powell, Monica Arenas‐Hernandez, Jenny Leung, Krystal Rawstron, Chioma Nwaogu, Richard Woolf, Andrew E. Pink, Jonathan Barker, Joseph F. Standing, Catherine H. Smith, Satveer K. Mahil   +16 more
wiley   +1 more source

Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial

Nature Communications
Although many high-income countries have regular COVID-19 vaccine booster schedules, there are limited data on the protective effects of some heterologous booster combinations.
John D. Hart, Eddy Fadlyana, Nadia Mazarakis, Nina Dwi Putri, Emma Watts, Kerryn A. Moore, Eleanor F. G. Neal, Djatnika Setiabudi, Muhammad Gilang Dwi Putra, Cattram Nguyen, Aqila Sakina Zhafira, Pratama Wicaksana, Robert Sinto, Dwi Oktavia, Rini Fajarani, Agnes Rengga Indrati, Chrysanti Murad, Yovita Hartantri, Hendarsyah Suryadinata, Yulia Sofiatin, Kusnandi Rusmil, Hindra I. Satari, Sri Rezeki. Hadinegoro, Cissy B. Kartasasmita, Julitasari Sundoro, Paul V. Licciardi, Claire von Mollendorf, Edward K. Mulholland   +27 more
doaj   +1 more source